These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25065457)

  • 21. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.
    Walley AY; Alperen JK; Cheng DM; Botticelli M; Castro-Donlan C; Samet JH; Alford DP
    J Gen Intern Med; 2008 Sep; 23(9):1393-8. PubMed ID: 18592319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine/Naloxone for Opioid Use Disorder.
    Zosel A; Hernandez-Meier J; Owen J
    J Opioid Manag; 2024; 20(4):B13. PubMed ID: 39321067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine Provision by Early Career Family Physicians.
    Tong ST; Hochheimer CJ; Peterson LE; Krist AH
    Ann Fam Med; 2018 Sep; 16(5):443-446. PubMed ID: 30201642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine.
    Barry DT; Fazzino T; Necrason E; Ginn J; Fiellin LE; Fiellin DA; Moore BA
    J Addict Med; 2016; 10(5):352-6. PubMed ID: 27504926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 26. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results of the evaluation of the California Hub and Spoke Program.
    Darfler K; Sandoval J; Pearce Antonini V; Urada D
    J Subst Abuse Treat; 2020 Jan; 108():26-32. PubMed ID: 31400985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teaching residents to prescribe buprenorphine for opioid use disorder: Insights from a community-based residency program.
    Cavitt L; St Louis J; Barr WB; Dono R; Weida N; Sorcinelli M
    J Subst Abuse Treat; 2022 Jan; 132():108621. PubMed ID: 34538691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
    Cunningham CO; Sohler NL; McCoy K; Kunins HV
    Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization.
    Kirane H; Drits E; Ahn S; Kapoor S; Morgenstern J; Conigliaro J; Enden J
    J Opioid Manag; 2019; 15(3):193-204. PubMed ID: 31343721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.
    Edelman EJ; Dinh AT; Moore BA; Schottenfeld RS; Fiellin DA; Sullivan LE
    J Addict Med; 2012 Jun; 6(2):159-65. PubMed ID: 22367499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder.
    Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S
    J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Buprenorphine Prescribing in Community Health Centers.
    Hartung DM; Voss RW; Bailey SR; Huguet N; Muench J
    JAMA Health Forum; 2024 Apr; 5(4):e240634. PubMed ID: 38669032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.
    Nguyen TD; Gupta S; Ziedan E; Simon KI; Alexander GC; Saloner B; Stein BD
    JAMA Intern Med; 2021 Apr; 181(4):562-565. PubMed ID: 33346795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.
    Lowenstein M; Kilaru A; Perrone J; Hemmons J; Abdel-Rahman D; Meisel ZF; Delgado MK
    Am J Emerg Med; 2019 Sep; 37(9):1787-1790. PubMed ID: 30803850
    [No Abstract]   [Full Text] [Related]  

  • 38. Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.
    Srivastava A; Kahan M; Leece P; McAndrew A
    Addict Sci Clin Pract; 2019 May; 14(1):18. PubMed ID: 31039821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Use Disorder Practice by Licensure Category in North Carolina.
    Hughes PM; Harless C; Ramage M; Fusco C; Ostrach B
    N C Med J; 2023 May; 84(3):188-193. PubMed ID: 39302287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.
    Wen H; Hockenberry JM; Borders TF; Druss BG
    Med Care; 2017 Apr; 55(4):336-341. PubMed ID: 28296674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.